✦ LIBER ✦

Secondary Ph-positive CML with a minority monosomy 7 clone

✍ Scribed by Herbert E. Auerbach; Theresa Stelmach; Julia G. LaGuette; John H. Glick; Jeffrey A. Kant; Peter C. Nowell

Book ID: 119103729
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 800 KB
Volume: 28
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(87)90367-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monosomy 7 in a girl with Ph1 positive c

Monosomy 7 in a girl with Ph1 positive chronic granulocytic leukemia

✍ P.J. Darbyshire; O.B. Eden 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Hyperleukocytotic secondary acute myeloi

Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML)

✍ Björn Hackanson; Anja Rückert; Michael Lübbert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

A clone with loss of the Y chromosome in

A clone with loss of the Y chromosome in Ph1-positive chronic myelocytic leukemia (CML)

✍ Elisabeth Gödde; Eyna von Zelewski 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Ph-positive CML in blastic phase with mo

Ph-positive CML in blastic phase with monosomy 7 in a down syndrome patient: Monitoring by interphase cytogenetics and demonstration of maternal allelic loss

✍ Laura Seghezzi; Claudia Dellavecchia; Emanuela Maserati; Antonella Minelli; Anna 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Reciprocal Relationship Between a Ph-Neg

Reciprocal Relationship Between a Ph-Negative Clone With Trisomy 8 Associated With Severe Myelodysplasia and a Ph-Positive Clone Following Imatinib Treatment in a Patient With Accelerated-Phase Chronic Myelogenous Leukemia (CML)

✍ Paulina Patchenko; Abraham Klepfish; Luba Trakhtenbrot; Rachel Rothman; Eliezer 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

## Cytarabine-Induced Neurotoxicity Responding to Methyl Prednisolone To the Editor: Neurotoxicity is a well-recognized complication following high-dose cytosine arabinoside (HIDAC). The pathophysiology of this toxicity is unknown, although an immune-mediated mechanism is hypothesized. We describe